European Equity pre-Market Summary - 4th September 2026: Equities continue to benefit from Waller's dovish comments, markets look ahead to US NFP

Pre-market summaries of this kind bundle a macro driver with a stock-specific tape, and the two behave differently. The macro leg, here an equities tailwind from dovish Fed commentary ahead of payrolls, is the standard setup in which a single official's remarks extend a move until the next labour print either validates or punctures it; sessions in that window have historically traded with compressed conviction and outsized sensitivity to the release rather than to anything in the European calendar. On the single-stock side, the corporate actions are the durable items: large-scale restructuring plans with margin targets have tended to be bought on announcement in the autos sector, with execution risk deferred, while ECB merger authorisation is a procedural step that removes a regulatory overhang rather than adding new information. Broker moves from named houses in integrated oils and refiners typically re-rate the peer set rather than the individual name, with the refining-tightness rationale pointing to the product-crack channel rather than crude outright. Patent litigation of the kind flagged is a long-dated item that rarely survives the session as a price driver. The tell for the day is whether the rate-driven bid holds into the US data or fades as positioning is squared ahead of it.